- Home
- MRNA vs ATI Comparison
MRNA vs ATI Comparison
Compare MRNA & ATI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- ATI
- Stock Information
- Founded
- MRNA 2010
- ATI 1960
- Country
- MRNA United States
- ATI United States
- Employees
- MRNA N/A
- ATI N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- ATI Steel/Iron Ore
- Sector
- MRNA Health Care
- ATI Industrials
- Exchange
- MRNA Nasdaq
- ATI Nasdaq
- Market Cap
- MRNA 9.2B
- ATI 11.2B
- IPO Year
- MRNA 2018
- ATI N/A
- Fundamental
- Price
- MRNA $24.62
- ATI $99.64
- Analyst Decision
- MRNA Hold
- ATI Strong Buy
- Analyst Count
- MRNA 15
- ATI 7
- Target Price
- MRNA $36.69
- ATI $105.43
- AVG Volume (30 Days)
- MRNA 12.2M
- ATI 1.6M
- Earning Date
- MRNA 11-06-2025
- ATI 10-28-2025
- Dividend Yield
- MRNA N/A
- ATI N/A
- EPS Growth
- MRNA N/A
- ATI 18.88
- EPS
- MRNA N/A
- ATI 3.10
- Revenue
- MRNA $2,232,000,000.00
- ATI $4,583,000,000.00
- Revenue This Year
- MRNA N/A
- ATI $6.53
- Revenue Next Year
- MRNA $10.38
- ATI $8.03
- P/E Ratio
- MRNA N/A
- ATI $32.04
- Revenue Growth
- MRNA N/A
- ATI 7.75
- 52 Week Low
- MRNA $23.04
- ATI $39.23
- 52 Week High
- MRNA $48.92
- ATI $103.64
- Technical
- Relative Strength Index (RSI)
- MRNA 45.38
- ATI 66.58
- Support Level
- MRNA $23.04
- ATI $93.87
- Resistance Level
- MRNA $27.10
- ATI $101.11
- Average True Range (ATR)
- MRNA 1.61
- ATI 3.60
- MACD
- MRNA -0.02
- ATI -0.17
- Stochastic Oscillator
- MRNA 26.54
- ATI 63.66
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About ATI ATI Inc.
ATI Inc supplies specialty metals to various end markets, including aerospace and defense, oil and gas, automotive, and electrical energy, among many others. The company's operating segment includes High-Performance Materials and Components and Advanced Alloys and Solutions. The majority of revenue is from the High-Performance Materials segment. The High-Performance Materials segment is focused on a wide range of high-performance specialty materials, parts, and components for several the majority of end markets, including the aerospace & defense, medical, and energy markets. Geographically, it operates in the United States, China, the United Kingdom, Germany, France, Canada, and Others, the majority is from the United States.